277 related articles for article (PubMed ID: 19101139)
1. Functional role of the KLF6 tumour suppressor gene in gastric cancer.
Sangodkar J; Shi J; DiFeo A; Schwartz R; Bromberg R; Choudhri A; McClinch K; Hatami R; Scheer E; Kremer-Tal S; Martignetti JA; Hui A; Leung WK; Friedman SL; Narla G
Eur J Cancer; 2009 Mar; 45(4):666-76. PubMed ID: 19101139
[TBL] [Abstract][Full Text] [Related]
2. Biology of Krüppel-like factor 6 transcriptional regulator in cell life and death.
Andreoli V; Gehrau RC; Bocco JL
IUBMB Life; 2010 Dec; 62(12):896-905. PubMed ID: 21154818
[TBL] [Abstract][Full Text] [Related]
3. A small interfering RNA targeting the KLF6 splice variant, KLF6-SV1, as gene therapy for gastric cancer.
Chen H; Chen L; Sun L; Zhen H; Li X; Zhang Q
Gastric Cancer; 2011 Oct; 14(4):339-52. PubMed ID: 21538018
[TBL] [Abstract][Full Text] [Related]
4. In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma.
Narla G; Kremer-Tal S; Matsumoto N; Zhao X; Yao S; Kelley K; Tarocchi M; Friedman SL
Oncogene; 2007 Jun; 26(30):4428-34. PubMed ID: 17297474
[TBL] [Abstract][Full Text] [Related]
5. Functional inactivation of the KLF6 tumor suppressor gene by loss of heterozygosity and increased alternative splicing in glioblastoma.
Camacho-Vanegas O; Narla G; Teixeira MS; DiFeo A; Misra A; Singh G; Chan AM; Friedman SL; Feuerstein BG; Martignetti JA
Int J Cancer; 2007 Sep; 121(6):1390-5. PubMed ID: 17514651
[TBL] [Abstract][Full Text] [Related]
6. The role of KLF6 and its splice variants in cancer therapy.
DiFeo A; Martignetti JA; Narla G
Drug Resist Updat; 2009; 12(1-2):1-7. PubMed ID: 19097929
[TBL] [Abstract][Full Text] [Related]
7. Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma.
Yea S; Narla G; Zhao X; Garg R; Tal-Kremer S; Hod E; Villanueva A; Loke J; Tarocchi M; Akita K; Shirasawa S; Sasazuki T; Martignetti JA; Llovet JM; Friedman SL
Gastroenterology; 2008 May; 134(5):1521-31. PubMed ID: 18471523
[TBL] [Abstract][Full Text] [Related]
8. Genetic alterations of the KLF6 gene in gastric cancer.
Cho YG; Kim CJ; Park CH; Yang YM; Kim SY; Nam SW; Lee SH; Yoo NJ; Lee JY; Park WS
Oncogene; 2005 Jun; 24(28):4588-90. PubMed ID: 15824733
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of the tumor suppressor Krüppel-like factor 6 (KLF6) by mutation or decreased expression in hepatocellular carcinomas.
Pan XC; Chen Z; Chen F; Chen XH; Jin HY; Xu XY
J Zhejiang Univ Sci B; 2006 Oct; 7(10):830-6. PubMed ID: 16972326
[TBL] [Abstract][Full Text] [Related]
10. Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread.
Narla G; DiFeo A; Yao S; Banno A; Hod E; Reeves HL; Qiao RF; Camacho-Vanegas O; Levine A; Kirschenbaum A; Chan AM; Friedman SL; Martignetti JA
Cancer Res; 2005 Jul; 65(13):5761-8. PubMed ID: 15994951
[TBL] [Abstract][Full Text] [Related]
11. Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer.
Reeves HL; Narla G; Ogunbiyi O; Haq AI; Katz A; Benzeno S; Hod E; Harpaz N; Goldberg S; Tal-Kremer S; Eng FJ; Arthur MJ; Martignetti JA; Friedman SL
Gastroenterology; 2004 Apr; 126(4):1090-103. PubMed ID: 15057748
[TBL] [Abstract][Full Text] [Related]
12. KLF6 allelic loss is associated with tumor recurrence and markedly decreased survival in head and neck squamous cell carcinoma.
Teixeira MS; Camacho-Vanegas O; Fernandez Y; Narla G; DiFeo A; Lee B; Kalir T; Friedman SL; Schlecht NF; Genden EM; Urken M; Brandwein-Gensler M; Martignetti JA
Int J Cancer; 2007 Nov; 121(9):1976-1983. PubMed ID: 17621627
[TBL] [Abstract][Full Text] [Related]
13. A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk.
Narla G; Difeo A; Reeves HL; Schaid DJ; Hirshfeld J; Hod E; Katz A; Isaacs WB; Hebbring S; Komiya A; McDonnell SK; Wiley KE; Jacobsen SJ; Isaacs SD; Walsh PC; Zheng SL; Chang BL; Friedrichsen DM; Stanford JL; Ostrander EA; Chinnaiyan AM; Rubin MA; Xu J; Thibodeau SN; Friedman SL; Martignetti JA
Cancer Res; 2005 Feb; 65(4):1213-22. PubMed ID: 15735005
[TBL] [Abstract][Full Text] [Related]
14. Growth inhibitory effect of Krüppel-like factor 6 on human prostatic carcinoma and renal carcinoma cell lines.
Cheng XF; Li D; Zhuang M; Chen ZY; Lu DX; Hattori T
Tohoku J Exp Med; 2008 Sep; 216(1):35-45. PubMed ID: 18719336
[TBL] [Abstract][Full Text] [Related]
15. KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis.
Narla G; DiFeo A; Fernandez Y; Dhanasekaran S; Huang F; Sangodkar J; Hod E; Leake D; Friedman SL; Hall SJ; Chinnaiyan AM; Gerald WL; Rubin MA; Martignetti JA
J Clin Invest; 2008 Aug; 118(8):2711-21. PubMed ID: 18596922
[TBL] [Abstract][Full Text] [Related]
16. Targeted reduction of KLF6-SV1 restores chemotherapy sensitivity in resistant lung adenocarcinoma.
Sangodkar J; DiFeo A; Feld L; Bromberg R; Schwartz R; Huang F; Terzo EA; Choudhri A; Narla G
Lung Cancer; 2009 Dec; 66(3):292-7. PubMed ID: 19328586
[TBL] [Abstract][Full Text] [Related]
17. Increased alternative splicing of the KLF6 tumour suppressor gene correlates with prognosis and tumour grade in patients with pancreatic cancer.
Hartel M; Narla G; Wente MN; Giese NA; Martignoni ME; Martignetti JA; Friess H; Friedman SL
Eur J Cancer; 2008 Sep; 44(13):1895-903. PubMed ID: 18691883
[TBL] [Abstract][Full Text] [Related]
18. Absence of mutation in the putative tumor-suppressor gene KLF6 in colorectal cancers.
Lièvre A; Landi B; Côté JF; Veyrie N; Zucman-Rossi J; Berger A; Laurent-Puig P
Oncogene; 2005 Nov; 24(48):7253-6. PubMed ID: 16044160
[TBL] [Abstract][Full Text] [Related]
19. Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.
Ito G; Uchiyama M; Kondo M; Mori S; Usami N; Maeda O; Kawabe T; Hasegawa Y; Shimokata K; Sekido Y
Cancer Res; 2004 Jun; 64(11):3838-43. PubMed ID: 15172991
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation.
Kremer-Tal S; Narla G; Chen Y; Hod E; DiFeo A; Yea S; Lee JS; Schwartz M; Thung SN; Fiel IM; Banck M; Zimran E; Thorgeirsson SS; Mazzaferro V; Bruix J; Martignetti JA; Llovet JM; Friedman SL
J Hepatol; 2007 Apr; 46(4):645-54. PubMed ID: 17196295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]